NCT05263882 2022-03-03
Gemcitabine Combined With Eribulin Regimen in the Treatment of Second-line Above Recurrent HER2-negative Breast Cancer
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 2 Unknown
Fifth Affiliated Hospital, Sun Yat-Sen University
The First Affiliated Hospital with Nanjing Medical University